Amorfrutins are potent antidiabetic dietary natural products
Open Access
- 16 April 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (19), 7257-7262
- https://doi.org/10.1073/pnas.1116971109
Abstract
Given worldwide increases in the incidence of obesity and type 2 diabetes, new strategies for preventing and treating metabolic diseases are needed. The nuclear receptor PPARγ (peroxisome proliferator-activated receptor gamma) plays a central role in lipid and glucose metabolism; however, current PPARγ-targeting drugs are characterized by undesirable side effects. Natural products from edible biomaterial provide a structurally diverse resource to alleviate complex disorders via tailored nutritional intervention. We identified a family of natural products, the amorfrutins, from edible parts of two legumes, Glycyrrhiza foetida and Amorpha fruticosa, as structurally new and powerful antidiabetics with unprecedented effects for a dietary molecule. Amorfrutins bind to and activate PPARγ, which results in selective gene expression and physiological profiles markedly different from activation by current synthetic PPARγ drugs. In diet-induced obese and db/db mice, amorfrutin treatment strongly improves insulin resistance and other metabolic and inflammatory parameters without concomitant increase of fat storage or other unwanted side effects such as hepatoxicity. These results show that selective PPARγ-activation by diet-derived ligands may constitute a promising approach to combat metabolic disease.Keywords
This publication has 40 references indexed in Scilit:
- A role for central nervous system PPAR-γ in the regulation of energy balanceNature Medicine, 2011
- Brain PPAR-γ promotes obesity and is required for the insulin–sensitizing effect of thiazolidinedionesNature Medicine, 2011
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5Nature, 2010
- Pparγ2 Is a Key Driver of Longevity in the MousePLoS Genetics, 2009
- Drug Discovery and Natural Products: End of an Era or an Endless Frontier?Science, 2009
- Identifying the proteins to which small-molecule probes and drugs bind in cellsProceedings of the National Academy of Sciences of the United States of America, 2009
- Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agentProceedings of the National Academy of Sciences of the United States of America, 2009
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Nutrigenomics: goals and strategiesNature Reviews Genetics, 2003